Global goals of oxygen metabolism and intestinal integrity.
Sautner
T
T
Riegler
M
M
Függer
R
R
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output; D004195:Disease Models, Animal; D004837:Epinephrine / Q000627:therapeutic use; D004926:Escherichia coli; D006863:Hydrogen-Ion Concentration; D007413:Intestinal Mucosa / Q000098:blood supply / Q000378:metabolism*; D008070:Lipopolysaccharides / Q000633:toxicity; D009638:Norepinephrine / Q000627:therapeutic use; D010101:Oxygen Consumption; D018805:Sepsis / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D013152:Splanchnic Circulation; D013552:Swine; D018746:Systemic Inflammatory Response Syndrome / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D008070:Lipopolysaccharides; D014662:Vasoconstrictor Agents; D009638:Norepinephrine; D004837:Epinephrine